Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices Illustrated Edition
| Robin Feldman (Author) Find all the books, read about the author, and more. See search results for this author |
Use the Amazon App to scan ISBNs and compare prices.
Books with Buzz
Discover the latest buzz-worthy books, from mysteries and romance to humor and nonfiction. Explore more
Frequently bought together

- +
- +
Customers who viewed this item also viewed
From the Publisher
Profits everyone love - except those who pay the bills
In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. This system of perverse incentives has delivered the kind of exorbitant drug prices - and profits - that everyone loves except for those who pay the bills.
"Quite simply, if you are an American reading this and you only read a single book between now and the November 2020 elections, it needs to be this one." Jeff Sexton, bookanon.com
“Drugs, Money, and Secret Handshakes” is one hundred power-packed pages of rich data and sober analysis." Louis Garguilo, Chief Editor, outsourcedpharma.com
"In this lucid and supremely upsetting book, Robin Feldman lays bare the multilayered, perverse incentives that reward pharmaceutical companies for hiking their branded drug prices into the stratosphere. Both houses of Congress should be locked in a room until they've read this book and enacted the remedies she proposes. Prosecutors should read it carefully, too." Roger Parloff, Legal Journalist
Editorial Reviews
Review
'In this lucid and supremely upsetting book, Robin Feldman lays bare the multilayered, perverse incentives that reward pharmaceutical companies for hiking their branded drug prices into the stratosphere. Both houses of Congress should be locked in a room until they've read this book and enacted the remedies she proposes. Prosecutors should read it carefully, too.' Roger Parloff, Legal Journalist
''Everyone has a limit. Every budget has an endpoint' cannot apply to an industry that is consistently anti-competitive and monopolistic. Feldman offers potential solutions and exposes the limits inherent in each. Consumers who find this salient will be motivated to investigate further and alleviate their information gaps.' S. M. Mohammed, Choice
Book Description
About the Author
Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.
Product details
- Publisher : Cambridge University Press; Illustrated edition (April 11, 2019)
- Language : English
- Hardcover : 196 pages
- ISBN-10 : 1108482457
- ISBN-13 : 978-1108482455
- Item Weight : 1.01 pounds
- Dimensions : 6 x 0.25 x 9 inches
- Best Sellers Rank: #943,842 in Books (See Top 100 in Books)
- #151 in Health Law (Books)
- #4,225 in Law (Books)
- #8,180 in Industries (Books)
- Customer Reviews:
About the author

Discover more of the author’s books, see similar authors, read author blogs and more
Customer reviews
Customer Reviews, including Product Star Ratings help customers to learn more about the product and decide whether it is the right product for them.
To calculate the overall star rating and percentage breakdown by star, we don’t use a simple average. Instead, our system considers things like how recent a review is and if the reviewer bought the item on Amazon. It also analyzed reviews to verify trustworthiness.
Learn more how customers reviews work on AmazonTop reviews from the United States
There was a problem filtering reviews right now. Please try again later.
Big Pharma, while they have life saving drugs is also a Big Bully to us patients. We all know the healthcare system is messed up, it's a jumbled ball of yarn that the government keeps making worse instead of better. And the pharmaceutical industry is just as messed up and corrupt. I never knew quite how corrupt until reading this book. The author does an exquisite job of laying out how the industry is structured and analyzing all the ways the drug prices get raised. It is alarming, it is scary, it is horrifying how the current system is structured to rob the patient blind while padding the pockets of drug companies. PBM's (pharmacy benefit managers) and insurance companies. Within reading the first 15% of this book, I had 7 solutions to help lower drug costs. And that's just me, one lone reader. Now imagine if the powers that be, that we elected to be our voice and our feet to move justice would take the time to really read this, research it and discuss solutions what could happen!
I have two diseases that require extensive medicines to keep me somewhat healthy - Multiple Sclerosis and Congestive Heart Failure. I have no problem paying a premium for a product or service that is of extensive value to me. And I understand the need for companies to make a profit. I have no problem with that. One of the medicines I take for MS keeps me walking and out of a wheelchair (I consider that to be extensive value). What I do have a problem with, a big point in this book, is why is that medicine now $58,000 a year when 20 years ago it was $30,000 a year? And there is a generic on the market now that is $36,000 a year. You want me to believe in 20 years the pharmaceutical company hasn't found a more cost efficient way to manufacture this medicine? And with seven other competitive MS medicines out there, this is not an issue of cost and demand. As the title says, there is alot of money and secret handshakes that go into this dishonesty. The book points out on average a brand name drug has a 76% profit margin.
A huge part of the deception is this middle group of players who are the ones determining coverage levels for patients and the formularies for insurance companies. Someone in a suit is sitting in an office making a decision on what medicine I should be allowed access to based on how much money they are getting paid, not on what is in the best interest of my disease and health, as determined by my doctor.
There are moral, ethical and legal concerns raised in this book that as a country we need to address. The author does a spot on job of backing up everything with solid facts, figures, examples and legal cases. In the end the author offers a few solutions that could be pursued to start the conversation and get the ball rolling. If you take the time to read this book, I feel confident you will find additional ideas and potential solutions as I did (by books end I had 16. Not saying all would work or are even feasible, but it's a start). The point being that if we can get the right minds to the table, there are solutions out there where patients could get affordable medicine that won't break the bank while still allowing the pharmaceutical companies to make a decent profit.
My thanks to the author, publisher and netgalley for a copy of this book in exchange for an honest review.
Robin Feldman also shines a light onto the seedy little tricks pharmaceutical companies employ to keep prices high on drugs that have been around for a very long time. Using recycling and recombination strategies to obtain new patents to keep prices high on pharmaceuticals that would have otherwise become more affordable is just one of the sneaky techniques they employ.
Drugs, Money and Secret Handshakes is an apt title. The book is both interesting and educational.
While there's some good information, the author is selective about which examples they use. Counter examples are rarely presented and often mischaracterized.
It is definitely not for policymakers or scholars as suggested by the Amazon book description. It's may serve as a perspective-based introduction to the subject for general interest readers.
I don't know if the author is unaware of the industry's history and cases that don't fit her narrative, or if she deliberately excluded them to make for a better story, but the reason doesn't mater. The effect of these omissions is to leave readers misinformed.








